Did you know - Singapore-based Nanyang Biologics is using AI to unlock the therapeutic potential of natural compounds — and they’re doing it 68% faster and at a fraction of the cost.
Powered by Equinix AI-ready data centers and global digital infrastructure, they’ve built a Drug-Target Interaction Graph Neural Network (DTIGN) to screen over a billion natural compounds and accelerate early-stage drug development.
- 90% reduction in R&D infrastructure costs
- 68% acceleration in discovery timelines
- 27% improvement in bioactivity prediction accuracy
- Low-latency data access via Equinix Fabric and NVIDIA/HPE-powered environments
Crazy how the line is blurring between biotech and infrastructure - we’re seeing data gravity and interconnection emerge as critical enablers of innovation — even in traditionally lab-heavy fields.
- How is your industry leveraging AI to speed up discovery or innovation?
- What role does data proximity play in your AI workloads?
- Is the next big biotech breakthrough going to come from infrastructure?
Let’s talk AI, science, and speed — and what it takes to move from hypothesis to health impact.
Updated 3 months ago
Version 1.0